Guardant Health, Inc. ( GH) - Stock Earnings
GH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026, midnight | — / — | — | — / — | — |
GH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -92.7 million USD | 265.2 million USD |
| 2025Q4 | -128.5 million USD | 281.3 million USD |
| 2026Q1 | -112.1 million USD | 301.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -479.4 million USD | 563.9 million USD |
| 2024 | -436.4 million USD | 739.0 million USD |
| 2025 | -416.3 million USD | 982.0 million USD |
| 2026 Est. | — | — |
GH
Price: $150.13
Earnings Per Share: -3.40 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 409714
Market Capitalization: 22.3 billion